Target intelligence / Profile preview

Ventral intermediate nucleus of the thalamus (Vim)

Target
Vim
Molecular classification
Other
01

Overview

The Ventral intermediate nucleus of the thalamus (Vim) is a specific anatomical region within the motor thalamus that functions as a key relay node in the cerebello-thalamo-cortical pathway (StatPearls, 2023). It receives dense excitatory projections from the contralateral cerebellar dentate nucleus and sends efferents primarily to the primary motor cortex (PubMed PMID: 30251571). While not a molecular target such as a receptor or enzyme, the Vim is a well-established therapeutic target for neurosurgical interventions, including Deep Brain Stimulation (DBS) and Magnetic Resonance-guided Focused Ultrasound (MRgFUS) (NIH, 2022). These procedures are primarily indicated for the management of medication-refractory essential tremor and tremor-dominant Parkinson's disease (Wikipedia, 2024). By delivering high-frequency electrical pulses or creating a focal thermal lesion, clinicians can effectively disrupt the pathological rhythmic oscillations within the circuit that manifest as tremor (PubMed PMID: 29733566). This anatomical targeting allows for precise symptomatic relief in patients who do not respond to systemic pharmacological therapies.

Other names
Nucleus ventralis intermediusVim nucleusVentral intermediate thalamic nucleusVentral lateral posterior nucleus, vestibular part
02

Mechanism of action

The Vim is targeted via high-frequency electrical stimulation (Deep Brain Stimulation) or thermal ablation (Thalamotomy) to modulate the cerebello-thalamo-cortical circuit and suppress pathological tremor oscillations (StatPearls, 2023; PubMed PMID: 29733566).

03

Biological functions

Other
04

Disease associations

Neurodegenerative diseaseOther
05

Safety considerations

Intracranial hemorrhageDysarthriaParesthesiaGait ataxiaSurgical site infectionHardware failure (in DBS)
06

Biomarkers

Tremor amplitude and frequency (accelerometry)Microelectrode recording (MER) spike patternsStructural MRI (T1/T2/DTI) for target localization

Beyond the preview

Go deeper on Ventral intermediate nucleus of the thalamus (Vim).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ventral intermediate nucleus of the thalamus (Vim).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call